124 related articles for article (PubMed ID: 36367284)
1. Clinical big-data-based design of GLUT2-targeted carbon nanodots for accurate diagnosis of hepatocellular carcinoma.
Heo HJ; Park Y; Lee JH; Kim Y; Kim EK; Kim GH; Yu Y; Park SY; Seo HB; Pak K; Goh TS; Park S; Oh SO; Kwon W; Kim YH
Nanoscale; 2022 Nov; 14(45):17053-17064. PubMed ID: 36367284
[TBL] [Abstract][Full Text] [Related]
2. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
4. A novel carbon-nanodots-based theranostic nano-drug delivery system for mitochondria-targeted imaging and glutathione-activated delivering camptothecin.
Gong X; Wang Z; Zhang L; Dong W; Wang R; Liu Y; Song S; Hu Q; Du F; Shuang S; Dong C
Colloids Surf B Biointerfaces; 2022 Oct; 218():112712. PubMed ID: 35921692
[TBL] [Abstract][Full Text] [Related]
5. Improving the biocompatibility of carbon nanodots for cell imaging.
Mao QX; Han L; Shu Y; Chen XW; Wang JH
Talanta; 2016 Dec; 161():54-61. PubMed ID: 27769444
[TBL] [Abstract][Full Text] [Related]
6. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An
Xu YH; Yang J; Meng J; Wang H
Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234
[TBL] [Abstract][Full Text] [Related]
7. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
[TBL] [Abstract][Full Text] [Related]
8. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
[TBL] [Abstract][Full Text] [Related]
9. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
[TBL] [Abstract][Full Text] [Related]
10. Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance.
Lei Y; Hu Q; Gu J
Pathol Oncol Res; 2020 Apr; 26(2):1331-1340. PubMed ID: 31407220
[TBL] [Abstract][Full Text] [Related]
11. Dual-ligand functionalized carbon nanodots as green fluorescent nanosensors for cellular dual receptor-mediated targeted imaging.
Du F; Zhao X; Lu W; Guo Z; Shuang S; Dong C
Analyst; 2019 Nov; 144(22):6729-6735. PubMed ID: 31612877
[TBL] [Abstract][Full Text] [Related]
12. Targeted Multifunctional Nanoplatform for Imaging-Guided Precision Diagnosis and Photothermal/Photodynamic Therapy of Orthotopic Hepatocellular Carcinoma.
Qi S; Liu G; Chen J; Cao P; Lei X; Ding C; Chen G; Zhang Y; Wang L
Int J Nanomedicine; 2022; 17():3777-3792. PubMed ID: 36065288
[TBL] [Abstract][Full Text] [Related]
13. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
Wang Z; Han YJ; Huang S; Wang M; Zhou WL; Li HS; Wang QS; Wu HB
Amino Acids; 2018 Feb; 50(2):309-320. PubMed ID: 29204748
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Examination and Intraoperative Identification of Hepatocellular Carcinoma Using a Targeted Bimodal Imaging Probe.
Jin Y; Wang K; Tian J
Bioconjug Chem; 2018 Apr; 29(4):1475-1484. PubMed ID: 29544252
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel melatonin-modified near-infrared fluorescent probe for in vivo hepatocellular carcinoma imaging.
Huang M; Zhao Q; Ye Z; Xu D; Tang S; Jiang T
Anal Methods; 2020 Oct; 12(37):4556-4561. PubMed ID: 33001063
[TBL] [Abstract][Full Text] [Related]
16. Green synthesis of fluorescent carbon nanodots from sage leaves for selective anticancer activity on 2D liver cancer cells and 3D multicellular tumor spheroids.
Sawalha S; Abdallah S; Barham A; Badawi H; Barham Z; Ghareeb A; Misia G; Collavini S; Silvestri A; Prato M; Assali M
Nanoscale Adv; 2023 Oct; 5(21):5974-5982. PubMed ID: 37881717
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
18. Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.
Kim DH; Choi SH; Byun JH; Kang JH; Lim YS; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
J Hepatol; 2019 Sep; 71(3):534-542. PubMed ID: 31108157
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Koda W; Inoue D; Ogi T; Yoshida K; Gabata T
Eur Radiol; 2020 Jun; 30(6):3438-3447. PubMed ID: 32064560
[TBL] [Abstract][Full Text] [Related]
20. Dual-Color-Emitting Carbon Nanodots for Multicolor Bioimaging and Optogenetic Control of Ion Channels.
Kim H; Park Y; Beack S; Han S; Jung D; Cha HJ; Kwon W; Hahn SK
Adv Sci (Weinh); 2017 Nov; 4(11):1700325. PubMed ID: 29201627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]